# ClinicalTrials.gov record NCT04407234

> PeptideScanner retained ClinicalTrials.gov record NCT04407234 at 2026-07-30T18:49:14.741Z. Its registry update date was 2024-01-08, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct04407234-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-01-08
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04407234-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04407234-tirzepatide-v1.json
- Content SHA-256: `826a41c8dccd1c69755462e3cb66b6a4d61756e9e3bd8ed31b9b7c7e7d43a225`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04407234 ([`ctg-observation-nct04407234-2024-01-08-d370bfac5047`](#source-ctg-observation-nct04407234-2024-01-08-d370bfac5047))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04407234 at 2026-07-30T18:49:14.741Z. Its registry update date was 2024-01-08, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct04407234-2024-01-08-d370bfac5047`](#source-ctg-observation-nct04407234-2024-01-08-d370bfac5047))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04407234 at 2026-07-30T18:49:14.741Z. Its registry update date was 2024-01-08, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct04407234-2024-01-08-d370bfac5047`](#source-ctg-observation-nct04407234-2024-01-08-d370bfac5047))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04407234-2024-01-08-d370bfac5047`](#source-ctg-observation-nct04407234-2024-01-08-d370bfac5047))

## Sources

<a id="source-ctg-observation-nct04407234-2024-01-08-d370bfac5047"></a>
- **ClinicalTrials.gov record NCT04407234 · retained source version 2024-01-08:d370bfac504714396df5ada86c8141f483a4c81692784b1a89a269ebcdfb66df** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04407234) (`ctg-observation-nct04407234-2024-01-08-d370bfac5047`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04407234." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04407234-tirzepatide-v1.json SHA-256: 826a41c8dccd1c69755462e3cb66b6a4d61756e9e3bd8ed31b9b7c7e7d43a225.